autoimmune-995x60 autoimmune-995x60

FEATURED ARTICLES

Lupus Research Alliance Enhances Clinical Trials for Patients
Lupus Research Alliance Enhances Clinical Trials for Patients

The Lupus Research Alliance is the largest non-profit health organization raising money for research into the cause, cure, treatment, and prevention of Lupus and its complications. The research programs funded are typically collaborations with hospitals, medical schools and universities, as well as pharmaceutical companies from around the world. While treatments are available, Farber notes they are far from perfect. This has led the Lupus Research Alliance to step up its efforts to improve clinical trials and get ned medicines to patients.

  • Eli Lilly Steps Up Focus On Autoimmune Diseases
    Eli Lilly Steps Up Focus On Autoimmune Diseases

    Managing patients having an autoimmune disease can present special challenges for researchers, from correctly diagnosing the disease to recruiting specific patients for clinical trials. I recently spoke with Chin Lee, global senior medical director in the immunology therapeutic area at Eli Lilly and Company. Lee discusses his decision to move from academia to pharma and the challenges inherent in performing clinical trials on autoimmune disease patients.

  • NEWS ROUNDUP: Pharma Invests In Patients, More Trials Use FitBit Trackers
    NEWS ROUNDUP: Pharma Invests In Patients, More Trials Use FitBit Trackers

    Clinical Leader news roundup for the week of April 11, 2016, with articles on pharma’s investment in patients, FitBit activity trackers in clinical trials, new Hep C combination treatment tested in Malaysia and Thailand, prostate and pancreatic cancer trials, the need for clinical trial participants, and making the most of clinical trial data.

  • NEWS ROUNDUP: Santa Claus, The Easter Bunny, And Patient Centricity?
    NEWS ROUNDUP: Santa Claus, The Easter Bunny, And Patient Centricity?

    Clinical Leader news roundup for the week of April 4, 2016, with articles on Patient recruitment via Twitter, NIH sponsors trial of anti-HIV antibody, diversity in clinical trials, INC Research partners with CISCRP, the use of apps in clinical trials, and the myth of patient centricity.

More Featured Articles

NEWS

More News